Arch Therapeutics, Inc.
ARTHDelisted- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001537561
Arch Therapeutics, Inc. was delisted in 2022; its insiders filed their last Form 4 on Sep 8, 2023; 1 institution reported holding it in 13F filings for Q3 2022, worth $0 in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Arch Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ARTH is no longer listed, and 13F filings after Q3 2022 list far fewer holders. See Q3 2022
- Institutional holders
- 1
- 0 vs. Q3 2022
- Shares held
- 15.0K
- 0 (0.0%) vs. Q3 2022
- Total value
- $0
- $0 vs. Q3 2022
- New holders
- 0
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 1 | $0 |
| Q3 2022 | 1 | $0 |
| Q2 2022 | 2 | $0 |
| Q1 2022 | 2 | $6.00K |
| Q4 2021 | 3 | $7.00K |
| Q3 2021 | 3 | $10.0K |
| Q2 2021 | 4 | $12.0K |
| Q1 2021 | 4 | $20.0K |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Arch Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bryn Mawr Trust Co | 15,000 | $0 | 0.00% | 00.0% | Unchanged |